Overview
Dent disease type 2 is a rare X-linked tubulopathy characterized by low-molecular-weight proteinuria, hypercalciuria, and proximal tubular dysfunction, often leading to nephrolithiasis, nephrocalcinosis, and kidney failure in affected males. 1Diagnosis
Key Diagnostic Criteria: Low-molecular-weight proteinuria, hypercalciuria, and evidence of proximal tubular dysfunction.
Recommended Tests:
- Urinary protein electrophoresis to identify low-molecular-weight proteins.
- 24-hour urine calcium levels to confirm hypercalciuria.
- Renal biopsy may be necessary in atypical cases to assess tubular pathology.
Grading: Diagnosis often relies on clinical presentation and supportive laboratory findings due to limited evidence. 1Management
First-Line Treatments:
- Thiazide diuretics to reduce hypercalciuria and prevent nephrolithiasis.
- Dietary modifications to limit calcium and oxalate intake.
Adjunctive Treatments:
- Potassium binders for hyperkalemia if present.
- Management of complications such as nephrolithiasis with appropriate interventions (e.g., lithotripsy).
Specific Drug Classes/Doses: Thiazide diuretics (dose varies; individualized based on response). 1Special Populations
Pregnancy: Limited data; close monitoring of renal function and calcium metabolism is advised. 1
Pediatrics: Early diagnosis and management crucial to prevent long-term renal damage; similar management principles apply with dose adjustments. 1
Elderly: Increased vigilance for complications like nephrocalcinosis and kidney failure; individualized care plans are essential. 1
Comorbidities: Management of comorbid conditions like hypertension and acidosis alongside Dent disease requires integrated care strategies. 1Key Recommendations
Diagnose Dent disease type 2 based on clinical presentation and supportive laboratory findings including low-molecular-weight proteinuria and hypercalciuria (Evidence: Expert opinion) 1
Initiate thiazide diuretics as first-line therapy to manage hypercalciuria and reduce nephrolithiasis risk (Evidence: Moderate) 1
Implement dietary modifications to control calcium and oxalate intake to complement pharmacological management (Evidence: Expert opinion) 1References
1 Bökenkamp A, Ariceta G, Böckenhauer D, Devuyst O, Emma F, van Bennekom D et al.. Dent disease: clinical practice recommendations. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025. link